Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Better Prognosis for Breast Cancer in Germany

04.05.2012
Excellent treatment results testify to high quality of care at Heidelberg University Hospital’s Breast Center / First publication of prospectively collected data in Germany

How successful is the interdisciplinary treatment of breast cancer? Since 2003, the Breast Center at Heidelberg University Hospital has systematically tracked the course of breast cancer in more than 3,000 patients and, as the first center in Germany, has published these significant prospective results: Eighty-six percent of the patients survived the first five years after onset of treatment, with 80 % of them remaining disease-free during this period. The evaluation was published online in February 2012 in the journal The Breast.

“The prognosis for breast cancer has further improved thanks to new treatment options and consistent interdisciplinary treatment,” said Prof. Christof Sohn, Managing Director of the Heidelberg University Women’s Hospital and Director of the Breast Center. This is proven by the results of treatment in Heidelberg. An evaluation of the German cancer registry for the period from 2000 to 2004 conducted by Robert Koch Institute in 2010 yielded a probability of 79.6 % for disease-free survival in the first five years after treatment. A current study by the German Cancer Research Center (DKFZ) that analyzed the data of 11 German cancer registries from the period from 2002 to 2006 yielded a probability of approx. 84 %. In the United States, according to the National Cancer Institute, this probability was 89 % for the period from 1999 to 2006.

Eighty-six percent of the patients were still alive five years after treatment

The interdisciplinary team in Heidelberg headed by Prof. Andreas Schneeweiss, head of the section of Gynecological Oncology at the National Center for Tumor Diseases and the Heidelberg University Hospital Women’s Hospital and by Dr. Jörg Heil, head physician and coordinator of the Heidelberg University Hospital Breast Center, evaluated the data of all 3,338 patients newly diagnosed with malignant breast cancer treated at Heidelberg University Hospital’s Breast Center from 2003 to 2010. Five years after initial treatment, 80 % were disease-free, i.e., the cancer had not recurred. In 15 % of the patients, a tumor had recurred in the breast and in 19 %, metastases had occurred, with some patients experiencing both. Eighty-six percent of the patients survived the first five years after initial diagnosis. Taking the deaths into account that were not attributed to the breast cancer, the evaluation showed that only 10 % of the patients died from breast cancer during the first five years after diagnosis.

Interdisciplinary tumor board provides recommendations for treatment

“Our results serve as a basis for further improving preventative care and treatment of breast cancer patients,” said Prof. Schneeweiss. “In this area, with the structures created at the National Center for Tumor Diseases in Heidelberg, we are setting the standards for other centers in Germany.” Since 2003, Prof. Schneeweiss has managed the meticulous documentation of all breast cancer cases, which now constitutes the data base for this and other such analyses and will continue to do so in the future. Prof. Schneeweiss is also the head of the interdisciplinary tumor board and is therefore responsible for drawing up the individual interdisciplinary treatment recommendations.
In 2003, the Breast Center at Heidelberg University Women’s Hospital was one of the first centers in Germany to be certified by the German Cancer Society and the German Society for Senology. Today, there are more than 200 certified breast centers in Germany. In 2006, the Breast Center was accredited by the European Society of Breast Cancer Specialists (EUSOMA). For patients, this means that an experienced team of physicians and modern treatment options ensure high-quality diagnostics and treatment through multidisciplinary cooperation. In 2011, Heidelberg University Hospital’s Breast Center treated over 600 newly diagnosed patients, making it one of Germany’s largest breast centers.

Literature:
J. Heil, A. Gondos, G. Rauch, F. Marmé, J. Rom, M. Golatta, H. Junkermann, P. Sinn, S. Aulmann, J. Debus, H. Hof, F. Schütz, H. Brenner, C. Sohn, A. Schneeweiss. Outcome analysis patients with primary breast cancer initially treated at a certified academic breast unit. The Breast (2012), doi:10.1016/j.breast.2012.01.009

J. Haberland, J. Bertz, U. Wolf, T. Ziese, B.M. Kurth: German cancer statistics 2004. BMC Cancer, 10 (2010), p. 52

E. Hiripi, A. Gondos, K. Emrich, B. Holleczek, A. Katalinic, S. Luttmann et al.: Survival from common and rare cancers in Germany in the early 21st century. Ann Oncol, 23 (2012), pp. 472–479

S. Altekruse, C. Kosary, M. Krapcho: SEER cancer statistics review, 1975–2007. National Cancer Institute (2010) http://seer.cancer.gov/csr/1975_2007/

Internet:
http://www.klinikum.uni-heidelberg.de/Brustzentrum.103928.0.html

Contact:
Dr. Jörg Heil
Head physician and coordinator of the
Heidelberg University Hospital Breast Center
phone +49 - 6221 56 77 22
e-mail: joerg.heil@med.uni-heidelberg.de

About Heidelberg University Hospital:
Heidelberg University Hospital and the Medical Faculty of Heidelberg University
Patient Care, Research and Teaching of International Standard
Heidelberg University Hospital is among the largest and most renowned medical centers in Germany. The Medical Faculty of Heidelberg University ranges among the internationally relevant biomedical research institutes in Europe. The common goal is to develop new therapies and to apply them rapidly for the benefit of the patient. The Hospital and the Faculty have approximately 11,000 employees and are active in training and qualification. In more than 50 departments, clinics and special departments with about 2,000 hospital beds, approximately 600,000 patients receive inpatient and outpatient treatment each year. There are currently about 3,600 aspiring doctors studying medicine in Heidelberg; the Heidelberg Curriculum Medicinale (HeiCuMed) is at the top of medical teaching and training in Germany.
Requests by journalists:
Dr. Annette Tuffs
Head of Public Relations and Press Department
University Hospital of Heidelberg and
Medical Faculty of Heidelberg
Im Neuenheimer Feld 672
D-69120 Heidelberg
Germany
phone: +49 6221 / 56 45 36
fax: +49 6221 / 56 45 44
e-mail: annette.tuffs(at)med.uni-heidelberg.de

Selected english press releases online:
http://www.klinikum.uni-heidelberg.de/presse

Dr. Annette Tuffs | idw
Further information:
http://www.klinikum.uni-heidelberg.de

More articles from Health and Medicine:

nachricht Norovirus evades immune system by hiding out in rare gut cells
12.10.2017 | University of Pennsylvania School of Medicine

nachricht Flexible sensors can detect movement in GI tract
11.10.2017 | Massachusetts Institute of Technology

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Ocean atmosphere rife with microbes

17.10.2017 | Life Sciences

Neutrons observe vitamin B6-dependent enzyme activity useful for drug development

17.10.2017 | Life Sciences

NASA finds newly formed tropical storm lan over open waters

17.10.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>